Top Page
Oxford Instruments
(OTC:OXIG)
Oxford Instruments (OXIG) vs. iShares MSCI United Kingdom ETF (EWC)
Oxford Instruments Business Overview & Revenue Model
Oxford Instruments Financial Statement Overview
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 500.60M | 470.40M | 444.70M | 367.30M | 318.50M |
| Gross Profit | 258.80M | 242.40M | 219.50M | 176.40M | 153.90M |
| EBITDA | 63.10M | 93.10M | 94.80M | 67.40M | 71.60M |
| Net Income | 26.00M | 50.70M | 58.60M | 38.60M | 41.80M |
Balance Sheet | |||||
| Total Assets | 604.80M | 606.30M | 572.00M | 514.00M | 450.70M |
| Cash, Cash Equivalents and Short-Term Investments | 94.10M | 97.80M | 112.70M | 96.40M | 128.00M |
| Total Debt | 40.90M | 47.40M | 43.90M | 28.90M | 37.90M |
| Total Liabilities | 228.70M | 240.60M | 228.00M | 197.60M | 184.50M |
| Stockholders Equity | 376.10M | 365.70M | 344.00M | 316.40M | 266.20M |
Cash Flow | |||||
| Free Cash Flow | 33.20M | 14.70M | 34.70M | 34.50M | 36.70M |
| Operating Cash Flow | 49.10M | 42.40M | 67.60M | 49.20M | 41.80M |
| Investing Cash Flow | -27.40M | -37.50M | -37.50M | -45.70M | -4.90M |
| Financing Cash Flow | -18.40M | -18.00M | -16.60M | -15.70M | -30.50M |
Oxford Instruments Technical Analysis
Oxford Instruments Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.14B | 21.90 | 11.07% | 1.93% | 4.71% | 0.43% | |
70 Outperform | £857.11M | 24.93 | 24.12% | 3.96% | -3.96% | -26.93% | |
69 Neutral | £4.08B | 17.51 | 17.33% | 1.87% | -11.09% | 65.87% | |
66 Neutral | £1.03B | 40.02 | 7.03% | 1.24% | 6.42% | -48.89% | |
62 Neutral | £517.10M | 24.54 | -6.45% | 2.78% | 3.08% | -16.36% | |
51 Neutral | $22.94M | 37.82 | -8.92% | ― | -46.97% | ― | |
48 Neutral | £92.78M | ― | -25.13% | ― | 2.41% | -16.47% |
Oxford Instruments Corporate Events
Oxford Instruments, a company involved in scientific and industrial instrumentation, announced the purchase of 30,000 of its own shares as part of a share buyback program. The shares were acquired at an average price of 1791.5901 pence each, with the total number of shares in issue now standing at 57,610,479. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc has announced its total voting rights and share capital as of July 31, 2025, which consists of 57,710,041 ordinary shares with voting rights. This information is crucial for shareholders to determine their reporting obligations under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2230.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced that Richard Tyson, their Chief Executive Officer, will step down from his role as a non-executive director at Videndum plc on 31 July 2025. This move may influence the company’s strategic focus and leadership dynamics, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc successfully held its Annual General Meeting on July 28, 2025, where all proposed resolutions were passed by shareholders. The resolutions included the adoption of the 2025 Annual Report, approval of the Directors’ Remuneration Report, declaration of a final dividend, and the election and re-election of several directors. The approval of these resolutions reflects strong shareholder support and positions the company to continue its strategic initiatives and maintain robust governance practices.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has executed a share buyback program, purchasing 34,086 of its own ordinary shares at an average price of 1893.2896 pence per share. This transaction, conducted through Numis Securities Limited, results in a total of 57,847,883 ordinary shares in issue, impacting the company’s capital structure and potentially enhancing shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has executed a share buyback program, purchasing 15,849 of its own ordinary shares at an average price of 1933.4282 pence per share. This move is part of a broader strategy to optimize capital structure and enhance shareholder value, resulting in a total of 57,921,969 shares in issue, which will impact the company’s voting rights and potentially influence shareholder decisions.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2500.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced a transaction involving its Chief Executive Officer, Richard Tyson, who acquired Partnership Shares and Matching Shares under the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, aligns with regulatory requirements and reflects the company’s commitment to aligning leadership interests with shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2230.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments, a company known for its advanced technology solutions, has executed a share buyback program, purchasing 8,384 of its own ordinary shares at an average price of 1981.7619 pence per share. This transaction, conducted through Numis Securities Limited, will result in a total of 58,046,142 ordinary shares in issue, impacting the company’s voting rights and potentially influencing shareholder interests.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2290.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc has announced a transaction involving the repurchase of its own shares as part of a share buyback program. The company purchased 25,378 ordinary shares at an average price of 1981.5245 pence per share, with the shares being cancelled. Following this transaction, the total number of ordinary shares in issue will be 58,054,526, which also represents the total number of voting rights in the company. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments PLC has announced a change in the voting rights held by BlackRock, Inc., a major stakeholder. As of July 3, 2025, BlackRock’s total voting rights in Oxford Instruments have decreased slightly to 9.96% from a previous position of 10.09%. This adjustment in holdings could impact the company’s shareholder dynamics and influence future corporate decisions.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments, a company involved in the development and production of high-technology tools and systems, has announced a transaction involving the repurchase of its own shares. The company executed a share buyback program, purchasing 6,309 ordinary shares at an average price of 1998.5814 pence per share, which will be canceled. This transaction reduces the total number of shares in issue to 58,120,119, impacting the company’s share structure and potentially influencing shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced the acquisition of 7,904 ordinary shares by Richard Tyson, the company’s Chief Executive Officer. The transactions were conducted on the London Stock Exchange on July 1 and July 2, 2025, at prices of £18.7400 and £19.2200 per share, respectively. This move is part of the company’s compliance with the EU Market Abuse Regulation, indicating a commitment to transparency and regulatory adherence.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has announced that as of June 30, 2025, its issued share capital with voting rights consists of 58,157,073 ordinary shares. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, impacting how they manage their interests in the company.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has applied for the block listing of 300,000 ordinary shares on the London Stock Exchange, which will be issued under the company’s Performance Share Plan. This move is expected to enhance the company’s financial flexibility and potentially strengthen its market position by aligning employee incentives with shareholder interests.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments, a company known for its advanced technology solutions, announced the purchase and cancellation of 4,512 of its own ordinary shares as part of its share buyback programme. This transaction, executed through Numis Securities Limited, is part of a strategic move to manage the company’s capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation. The buyback reflects the company’s confidence in its financial health and future prospects.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc has published its Annual Report for the fiscal year ending 31 March 2025, along with the Notice of its Annual General Meeting scheduled for 28 July 2025. These documents are available online and have been submitted to the National Storage Mechanism for inspection. This publication is a routine part of the company’s compliance with regulatory requirements, providing stakeholders with insights into its financial performance and strategic direction.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
BlackRock, Inc., a major shareholder, has increased its voting rights in Oxford Instruments PLC to 10.09%, crossing a significant threshold. This change in holdings, which was notified on June 23, 2025, reflects BlackRock’s strategic interest in the company, potentially influencing Oxford Instruments’ future governance and strategic decisions, thereby impacting stakeholders and market dynamics.
The most recent analyst rating on (GB:OXIG) stock is a Buy with a £27.50 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced the granting of nominally priced options to its Executive Directors under the Long Term Incentive Plan. The awards, granted to CEO Richard Tyson and CFO Paul Fry, are set to vest in July 2028, contingent on performance conditions and continued service. This move aligns with the company’s strategy to incentivize leadership and drive long-term growth, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments reported strong financial results for the 2024/25 fiscal year, with revenue exceeding £500 million for the first time, driven by growth in semiconductor and materials analysis sectors. The company announced the sale of its NanoScience quantum business for £60 million, allowing it to focus on high-growth areas and initiate a £50 million share buyback program, enhancing shareholder value and accelerating progress towards medium-term margin targets.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced the publication of its preliminary results for the year ended 31 March 2025, which will be released on 13 June following a delay requested by auditors BDO LLP. A presentation for analysts and investors will be held on the same day, with a live stream and recording available online. This announcement highlights the company’s commitment to transparency and its strategic positioning in the market, potentially impacting stakeholders by reinforcing confidence in its operational integrity and future growth prospects.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc has announced a transaction involving its Chief Executive Officer, Richard Tyson, who acquired Partnership Shares and Matching Shares in the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, aligns with the company’s compliance with the EU Market Abuse Regulation, reflecting a strategic move to enhance executive engagement and align interests with shareholders.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments PLC has announced a change in its shareholder structure, as Aberdeen Group plc has increased its voting rights to 5.263333% as of April 8, 2025. This acquisition of voting rights signifies a notable shift in stakeholder influence within the company, potentially impacting its strategic decisions and market positioning.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments has announced the sale of its quantum-focused business, NanoScience, to Quantum Design, International Inc. for £60 million. This strategic divestment allows Oxford Instruments to concentrate on its core markets of materials analysis, semiconductors, and healthcare & life sciences, aligning with its strategy to enhance shareholder value and meet medium-term margin targets. The sale is expected to complete in the third quarter of FY2025/26, subject to regulatory approvals, and will enable a £50 million share buyback, reflecting the company’s strong balance sheet and capital allocation policy.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc has announced a delay in the publication of its preliminary results for FY2024/25 due to additional time requested by its auditors, BDO LLP, to complete standard audit procedures. Despite the delay, the company had previously reported strong performance in line with market expectations in its full-year trading update. The presentation to analysts will be rescheduled, and the results will be announced at the earliest opportunity.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced that as of May 31, 2025, its issued share capital with voting rights consists of 58,159,363 ordinary shares. This figure is crucial for shareholders to calculate their interests in compliance with the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, impacting how they report changes in their holdings.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Oxford Instruments plc announced a transaction involving its CEO, Richard Tyson, who acquired Partnership Shares and Matching Shares under the company’s Share Incentive Plan. This transaction, conducted on the London Stock Exchange, reflects the company’s adherence to the EU Market Abuse Regulation, ensuring transparency and compliance in its managerial operations.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2240.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.